Acadian Asset Management LLC Merus N.V. Transaction History

Acadian Asset Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$18.33 - $27.18 $9,916 - $14,704	541 New	541 $14,000
Q2 2022 Aug 09, 2022	SELL	$13.98 - $29.25 $611,149 - $1.28 Million	-43,716 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$23.58 - $30.91 $145,134 - $190,251	-6,155 Reduced 12.34%	43,716 $1.15 Million
Q4 2021 Feb 10, 2022	SELL	$20.0 - $32.29 $885,260 - $1.43 Million	-44,263 Reduced 47.02%	49,871 $1.58 Million
Q3 2021 Nov 12, 2021	BUY	$16.48 - $27.23 $724,988 - $1.2 Million	43,992 Added 87.73%	94,134 $2.07 Million
Q2 2021 Aug 11, 2021	BUY	$20.0 - $25.48 $1 Million - $1.28 Million	50,142 New	50,142 $1.06 Million
Q4 2020 Feb 11, 2021	SELL	$11.4 - $18.36 $21,523 - $34,663	-1,888 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$10.57 - $16.0 $19,956 - $30,208	1,888 New	1,888 $23,000
Q2 2020 Aug 12, 2020	SELL	$10.5 - $17.36 $16,936 - $28,001	-1,613 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$11.34 - $19.44 $118,185 - $202,603	-10,422 Reduced 86.6%	1,613 $20,000
Q4 2019 Feb 06, 2020	BUY	$14.08 - $18.5 $38,579 - $50,690	2,740 Added 29.48%	12,035 $170,000
Q3 2019 Nov 07, 2019	SELL	$14.55 - $20.52 $19,788 - $27,907	-1,360 Reduced 12.76%	9,295 $165,000
Q2 2019 Aug 08, 2019	SELL	$12.93 - $16.83 $426 - $555	-33 Reduced 0.31%	10,655 $156,000
Q1 2019 May 09, 2019	SELL	$11.09 - $15.83 $183,284 - $261,622	-16,527 Reduced 60.73%	10,688 $157,000
Q3 2018 Oct 30, 2018	BUY	$18.47 - $26.39 $502,661 - $718,203	27,215 New	27,215 $537,000

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.